Target intelligence / Profile preview

Triglyceride biosynthesis pathway enzyme

Molecular classification
Enzyme
01

Overview

**Triglyceride biosynthesis pathway enzymes** are a group of enzymes that catalyze the stepwise formation of triglycerides (triacylglycerols), the body's main form of energy storage. The major, canonical pathway is the *glycerol-3-phosphate (Kennedy) pathway*, present in most tissues, and a secondary *monoacylglycerol pathway* predominates in the small intestine. Key enzymes in the canonical G3P pathway include: - **Glycerol-3-phosphate acyltransferase (GPAT)**: catalyzes the first, committed step converting glycerol-3-phosphate to lysophosphatidic acid. - **1-acylglycerol-3-phosphate acyltransferase (AGPAT)**: converts lysophosphatidic acid to phosphatidic acid. - **Phosphatidic acid phosphatase (PAP, mainly lipin proteins)**: hydrolyze phosphatidic acid to diacylglycerol. - **Diacylglycerol acyltransferase (DGAT, DGAT1 and DGAT2 isoforms)**: catalyze the final step attaching a fatty acyl-CoA to diacylglycerol to yield triglyceride[2][5][7]. Other enzymes involved can include acyl-CoA synthetase (activates fatty acids) and recently described alternative pathways involving proteins like DIESL and TMX1[6]. These enzymes are major regulators of energy homeostasis and lipid storage, and dysregulation is implicated in various diseases including obesity, type 2 diabetes, and fatty liver disease[1][7]. Multiple drugs target specific enzymes within this pathway (e.g., DGAT inhibitors) as potential metabolic disease therapeutics. **Note:** This "target" is a pathway and not a single molecular entity. Therefore, while individual enzymes in the pathway (e.g., diacylglycerol acyltransferase, or DGAT) are canonical drug targets and have specific abbreviations, the term "triglyceride biosynthesis pathway enzymes" collectively refers to a *group* of targets, not a specific molecule. This makes the entry *too broad* and *not strictly correct* as a single therapeutic target[2][5][7]. For structured data, each enzyme (GPAT, AGPAT, PAP/lipin, DGAT, etc.) should be its own canonical entry.

Other names
Triacylglycerol biosynthesis enzymeTG biosynthesis enzymeTAG biosynthesis enzymeenzymes of glycerol phosphate pathway (GPAT, AGPAT, PAP/lipin, DGAT)Kennedy pathway enzymemonoacylglycerol pathway enzyme
02

Mechanism of action

Inhibition of acyltransferases (e.g., DGAT inhibitors block the final step in triacylglycerol formation) - Modulation of lipogenesis through regulatory pathways

03

Biological functions

Lipid metabolismEnergy storageLipid biosynthesisCellular energy homeostasis
04

Disease associations

ObesityType 2 diabetesNon-alcoholic fatty liver diseaseCardiovascular diseaseMetabolic disorders
05

Safety considerations

Risk of hepatic steatosisAltered lipid metabolism can lead to metabolic derangementsPotential for gastrointestinal disturbances (especially with MTP or DGAT inhibitors)
06

Interacting drugs

Pradigastat (DGAT1 inhibitor)

2 more in the full profile.

07

Biomarkers

Circulating triglyceride levelsHepatic TG content (for fatty liver)Expression/activity of pathway enzymes (e.g., DGAT, GPAT levels)

Beyond the preview

Go deeper on Triglyceride biosynthesis pathway enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triglyceride biosynthesis pathway enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call